Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders

Open access

Abstract

The gut–brain axis (GBA) is a complex bidirectional communication network connecting the gut and brain. It involves neural, immune, and endocrine communication pathways between the gastrointestinal (GI) tract and the central nervous system (CNS). Perturbations of the GBA have been reported in many neurodegenerative disorders (NDDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), among others, suggesting a possible role in disease pathogenesis. The gut microbiota is a pivotal component of the GBA, and alterations in its composition, known as gut dysbiosis, have been associated with GBA dysfunction and neurodegeneration. The gut microbiota might influence the homeostasis of the CNS by modulating the immune system and, more directly, regulating the production of molecules and metabolites that influence the nervous and endocrine systems, making it a potential therapeutic target. Preclinical trials manipulating microbial composition through dietary intervention, probiotic and prebiotic supplementation, and fecal microbial transplantation (FMT) have provided promising outcomes. However, its clear mechanism is not well understood, and the results are not always consistent. Here, we provide an overview of the major components and communication pathways of the GBA, as well as therapeutic approaches targeting the GBA to ameliorate NDDs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu15214631

Cites

Statistics

Figures

Figure 1 Pathways involved in bidirectional communication within the gut–brain axis (GBA). They include neural, immune, and endocrine pathways. Neurotransmitters: dopamine, serotonin, norepinephrine, gamma-aminobutyric acid (GABA), etc. Cytokines: interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor-α (TNF-α), etc. Nutrients and metabolites: short-chain fatty acids (SCFAs), amine compounds, vitamins, neuroprecursors, etc. ACTH: adrenocorticotropic hormone; HPA: hypothalamic-pituitary-adrenal; CRH: corticotrophin-releasing hormone. Created with BioRender.com.
Figure 1 Pathways involved in bidirectional communication within the gut–brain axis (GBA). They include neural, immune, and endocrine pathways. Neurotransmitters: dopamine, serotonin, norepinephrine, gamma-aminobutyric acid (GABA), etc. Cytokines: interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor-α (TNF-α), etc. Nutrients and metabolites: short-chain fatty acids (SCFAs), amine compounds, vitamins, neuroprecursors, etc. ACTH: adrenocorticotropic hormone; HPA: hypothalamic-pituitary-adrenal; CRH: corticotrophin-releasing hormone. Created with BioRender.com.CC BY · PubMed Central
Figure 2 Hallmarks in the pathophysiology of neurodegenerative disorders caused by gut dysbiosis. Gut dysbiosis tends to promote the generation of proinflammatory cytokines and toxic metabolites, which in turn disrupt the integrity of the intestinal barrier, commonly referred to as “leaky gut”, and leads to an increased systemic circulation of inflammatory factors, microbes, and microbial products, thereby inciting systemic inflammation. Furthermore, the inflammatory status disrupts the blood–brain barrier (BBB), facilitating the entry of toxic metabolites like lipopolysaccharides (LPS) and β-N-methylamino-L-alanine (BMAA) into the brain, resulting in neuroinflammation and oxidative stress. Chronic neuroinflammation fosters the aggregation of pathological proteins, disrupting neuronal function and ultimately causing neuronal loss. Additionally, gut dysbiosis-induced chronic inflammation and oxidative stress impair autophagic clearance processes in both the gut and the brain, resulting in proteolysis dysfunction. Created with BioRender.com.
Figure 2 Hallmarks in the pathophysiology of neurodegenerative disorders caused by gut dysbiosis. Gut dysbiosis tends to promote the generation of proinflammatory cytokines and toxic metabolites, which in turn disrupt the integrity of the intestinal barrier, commonly referred to as “leaky gut”, and leads to an increased systemic circulation of inflammatory factors, microbes, and microbial products, thereby inciting systemic inflammation. Furthermore, the inflammatory status disrupts the blood–brain barrier (BBB), facilitating the entry of toxic metabolites like lipopolysaccharides (LPS) and β-N-methylamino-L-alanine (BMAA) into the brain, resulting in neuroinflammation and oxidative stress. Chronic neuroinflammation fosters the aggregation of pathological proteins, disrupting neuronal function and ultimately causing neuronal loss. Additionally, gut dysbiosis-induced chronic inflammation and oxidative stress impair autophagic clearance processes in both the gut and the brain, resulting in proteolysis dysfunction. Created with BioRender.com.CC BY · PubMed Central
Figure 3 Strategies to modify gut microbiota for neurodegenerative disorders treatment. They mainly include diet, prebiotics, probiotics, synbiotics, and fecal microbiota transplantation (FMT). These approaches primarily function by modifying microbial communities and producing microbial metabolites, such as neurotransmitters and SCFAs, to exert neuroprotective effects. The diet emphasizes the consumption of fruits, vegetables, legumes, and cereals. Prebiotics are compounds selectively utilized by beneficial gut microbes, promoting the growth of beneficial bacteria and the generation of their metabolic products. Probiotics are live, nonpathogenic microorganisms that confer health benefits when consumed in adequate amounts. Synbiotics are specialized formulations that combine prebiotics and probiotics, synergistically enhancing their viability and therapeutic effects. FMT aims to restore a healthy gut microbiome and enhance gut microbiota diversity and functionality by transferring rigorously screened donor fecal microbiota into the patient’s GI tract. Created with BioRender.com.
Figure 3 Strategies to modify gut microbiota for neurodegenerative disorders treatment. They mainly include diet, prebiotics, probiotics, synbiotics, and fecal microbiota transplantation (FMT). These approaches primarily function by modifying microbial communities and producing microbial metabolites, such as neurotransmitters and SCFAs, to exert neuroprotective effects. The diet emphasizes the consumption of fruits, vegetables, legumes, and cereals. Prebiotics are compounds selectively utilized by beneficial gut microbes, promoting the growth of beneficial bacteria and the generation of their metabolic products. Probiotics are live, nonpathogenic microorganisms that confer health benefits when consumed in adequate amounts. Synbiotics are specialized formulations that combine prebiotics and probiotics, synergistically enhancing their viability and therapeutic effects. FMT aims to restore a healthy gut microbiome and enhance gut microbiota diversity and functionality by transferring rigorously screened donor fecal microbiota into the patient’s GI tract. Created with BioRender.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 164 · Cited by 175

Research works printed but not linked: 1

  1. Sudo, N. (2016). The Gut-Brain Axis Dietary, Probiotic, and Prebiotic Interventions on the Microbiota, Elsevier Inc.

Metadata

Authors
Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M.
Affiliations
  • Università di Camerino (IT)
  • Zhengzhou University of Light Industry (CN)
Corresponding author
  • Wei, Tao
  • Eleuteri, Anna Maria
Venue
Nutrients
Publisher
MDPI AG
Published
2023-10-31
Volume
15
Issue
21
Pages
4631
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4388041827
Cited by
175
References
164
Citations by year
2026: 62 · 2025: 73 · 2024: 39 · 2023: 1
FWCI
4.61
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Unicam Scientific Publications (University of Camerino) (submittedVersion, cc-by)
Funders
University of Camerino and the Zhongyuan Science and Technology Innovation Leading Talent Project (224200510017)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
gut-brain axis, neurodegenerative diseases, gut microbiota, gut dysbiosis, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, neuroinflammation, dietary intervention, probiotics, prebiotics, fecal microbiota transplantation, microbial metabolites
MeSH terms
Gastrointestinal Microbiome, Brain-Gut Axis, Alzheimer Disease, Brain, Humans, Parkinson Disease, Neurodegenerative Diseases, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders. https://app.cochat.ai/papers/10.3390/nu15214631
The paper
Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023). Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders. Nutrients. https://doi.org/10.3390/nu15214631

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.